Blunted adrenocorticotropin and cortisol responses to corticotropin- releasing hormone stimulation in chronic fatigue syndrome

Acta Psychiatrica Scandinavica

Volumn 97, Issue 6, 1998, Pages 450-457

  Scott, L V ^a   Medbak, S ^a   Dinan, T G ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Adrenocorticotropin; Chronic fatigue syndrome; Corticotropinreleasing hormone; Cortisol; Hypothalamic pituitary adrenal axis

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; HYDROCORTISONE;

ADULT; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; COMORBIDITY; FEMALE; HORMONAL REGULATION; HORMONE RELEASE; HORMONE RESPONSE; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; MALE; NEUROSECRETORY CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

EID: 0031866106     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1998.tb10030.x     Document Type: Article

References (38)

1. VALE W, SPIESS J, RIVIER C, RIVIER J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and ß-endorphin. Science 1981: 213: 1394-1395.
2. SALATA R, JARRETT D, VERBALIS J, ROBINSON J. Vasopressin stimulation of adrenocorticotropin hormone (ACTH) in humans. J Clin Invest 1988: 81: 766-774.
3. DEBOLD C, SHELDON W, DECHERNEY G et al. Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-rcleasing factor. J Clin Invest 1983: 73: 533-538.
4. LAMBERTS S, VERLEUN S, OOSTERON R, DEJONG F, HACKENG W. Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man. J Clin Endocrinol Metab 1984: 58: 298-303.
5. DE GOEIJ D, DIJKSTRA H, TILDERS F. Chronic psychosocial stress enhances vasopressin, but not corticotropin-releasing factor, in the external zone of the median eminence in male rats: relationship to subordinate status. Endocrinology 1984: 131: 847-853.
6. VON BARDELEBEN U, HOLSBOER F, STALLA G, MULLER O. Combined administration of corticotropin-rcleasing factor and vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects. Life Sci 1985: 37: 1613-1618.
7. HOLSBOER F, VON BARDELEBEN U, GERKEN A, MULLER O. ACTH, cortisol and corticosterone output after ovine corticotropin-releasing factor challenge during depression and after recovery. Biol Psychiatry 1984: 20: 276-286.
8. HOLSBOER F, VON BARDELEBEN U, GERKEN A et al. Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression. N Engl J Med 1984: 311: 1127.
9. GOLD P, GWIRSTMAN H, AVERGINOS P et al. Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa: pathophysiological mechanisms in normal and underweight patients. N Engl J Med 1986: 314: 1335-1342.
10. KELLER-WOOD M, DALLMAN M. Corticosteroid inhibition of ACTH secretion. Endocrinol Rev 1984: 5: 1-24.
11. GOLD P, LICINIO J, WONG M, CHROUSOS G. Corticotropin-releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs. Ann NY Acad Sci 1995: 77: 716-729.
12. DEMITRACK M, DALE J, STRAUS S et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome. J Clin Endocrinol Metab 1991: 73: 1224-1234.
13. FUKUDA K, STRAUS S, HICKIE I et al. The chronic fatigue syndrome: a comprehensive approach to its treatment and study. Ann Intern Med 1994: 12: 953-959.
14. BEARN J, ALLAIN T, COSKERAN P et al. Neuroendocrine responses to d-fenfluramine and insulin-induced hypoglycaemia in chronic fatigue syndrome. Biol Psych 1995: 37: 245-252.
15. DINAN T, MAJEED T, LAVELLE E, SCOTT LV, BERTI C, BEHAN P. Serotonin-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome. Psychoneuroendocrinology 1997: 22: 261-268.
16. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, revised 4th edn. Washington, DC: American Psychiatric Association Press, 1994.
17. RAF H, FINDLING JW. A new immunoradiometric assay for corticotropin evaluated in normal subjects and patients with Cushing's syndrome. Clin Chemistry 1989: 35: 595-600.
18. DASH RJ, ENGLAND BJ, MIDGLEY AR, NISWENDER GD. A specific non-chromatograph radioimmunoassay for human cortisol. Steroids 1975: 26: 647-661.
19. Statistical Graphics Corporation. Statgraphics version 2.7. New York: Statistical Graphics Corporation, 1987.
20. CLEARE A, WESSELEY S. Chronic fatigue syndrome: a stress disorder? (review). Br J Hosp Med 1996: 55: 571-574.
21. AMSTERDAM J, MARINELLI D, ARGER P, WINOKUR A. Assessment of adrenal gland volumes by computer-assisted tomography in depressed patients and healthy volunteers. Psychiatr Res 1987: 21: 189-197.
22. RUBIN R, PHILLIPS J, SADOW T. Adrenal gland volume in major depression. Arch Gen Psychiatry 1995: 52: 213-218.
23. α 1 24) stimulation test in depressed patients and in healthy subjects. Am J Psychiatr 1983: 140: 907-909.
24. DICKSTEIN G, SCHECHNER C, NICHOLSON W et al. Adrenocorticotropin stimulation test: effects of basal cortisol levels, time of day and suggested new sensitive low-dose test. J Clin Endocrinol Metab 1991: 72: 773-778.
25. DE BECKER P, DE MEIRLER K, JOOS E et al. Attenuated DHEA response to i.v. ACTH injection in patients with chronic fatigue syndrome. Poster communication. First World Congress on Chronic Fatigue Syndrome and Related Disorders, Brussels, 1995.
26. HARKNESS J, RICHTER M, PANAYI G et al. Circadian variation in disease activity in rheumatoid arthritis. Br Med J 1982: 284: 551-553.
27. CROFFORD L, PILLEMER S, KALOGERAS K et al. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheumatol 1994: 37: 1583-1592.
28. SMYTH JM, OCKENFELS MC, GORIN AA et al. Individual differences in the diurnal cycle of cortisol. Psychoneuroendocrinology 1997: 2: 89-105.
29. SCHULTE H, CHROUSOS G, OLDFIELD E, GOLD P, CUTLER G, LORIAUX D. Ovine corticotropin-releasing factor administration in normal men. Horm Res (Basel) 1985: 21: 69-74.
30. TRAINER P, FARIA M, NEWELL-PRICE J et al. A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis. J Clin Endocrinol Metab 1995: 80: 412-417.
31. ANTONI F. Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front Neuroendocrinology 1993: 14: 76-122.
32. BAKHEIT AM, BEHAN PO, WATSON WS, MORTON JJ. Abnormal arginine vasopressin and water metabolism in patienrs with chronic fatigue syndrome. Acta Neurol Scand 1993: 87: 234-238.
33. DEMITRACK MA. Neuroendocrine correlates of chronic fatigue syndrome: a brief review. J Psychiatr Res 1997: 31: 69-82.
34. PATCHEV VK, KALOGERAS KT, ZELAZOWSKI P et al. Increased plasma concentrations, hypothalamic content, and in vitro release of arginine vasopressin in inflammatory disease-prone hypothalamic corticotropin hormone-deficient Lewis rats. Endocrinology 1988: 131: 1453-1457.
35. KELLNER M, WIEDMANN K, HOLSBOER F. Atrial natriuretic factor inhibits the CRH-stimulated secretion of ACTH and cortisol in man. Life Sci 1992: 50: 1835-1842.
36. EHLERS CL, KUPFER DJ. Hypothalamic peptide modulation of sleep EEG in depression: a further application of the S-process hypothesis. Biol Psychiatry 1987: 22: 513-517.
37. STEIGER A, GULDNER J, KNISATSCHEK H et al. Effects of growth-hormone releasing hormone and somatostatin on sleep EEG and nocturnal hormone secretion in male controls. Neuroendocrinology 1992: 56: 566-573.
38. LEESE G, CHATTINGTON P, FRASER W et al. Short-term nightshift work mimics the pituitary-adrenal dysfunction in chronic fatigue syndrome. J Clin Endocrinol Metab 1996: 81: 1867-1870.